422 related articles for article (PubMed ID: 29500798)
1. Safety Communication Tools and Healthcare Professionals' Awareness of Specific Drug Safety Issues in Europe: A Survey Study.
de Vries ST; van der Sar MJM; Coleman AM; Escudero Y; Rodríguez Pascual A; Maciá Martínez MÁ; Cupelli A; Baldelli I; Šipić I; Andrić A; Michan L; Denig P; Mol PGM;
Drug Saf; 2018 Jul; 41(7):713-724. PubMed ID: 29500798
[TBL] [Abstract][Full Text] [Related]
2. Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences.
de Vries ST; van der Sar MJM; Cupelli A; Baldelli I; Coleman AM; Montero D; Šipić I; Andrić A; Wennberg A; Ahlqvist-Rastad J; Denig P; Mol PGM;
Drug Saf; 2017 Aug; 40(8):729-742. PubMed ID: 28540672
[TBL] [Abstract][Full Text] [Related]
3. Healthcare professionals' self-reported experiences and preferences related to direct healthcare professional communications: a survey conducted in the Netherlands.
Piening S; Haaijer-Ruskamp FM; de Graeff PA; Straus SM; Mol PG
Drug Saf; 2012 Nov; 35(11):1061-72. PubMed ID: 23061782
[TBL] [Abstract][Full Text] [Related]
4. Knowledge of Adverse Drug Reaction Reporting and the Pharmacovigilance of Biological Medicines: A Survey of Healthcare Professionals in Ireland.
O'Callaghan J; Griffin BT; Morris JM; Bermingham M
BioDrugs; 2018 Jun; 32(3):267-280. PubMed ID: 29721705
[TBL] [Abstract][Full Text] [Related]
5. A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.
Mol PG; Straus SM; Piening S; de Vries JT; de Graeff PA; Haaijer-Ruskamp FM
Drug Saf; 2010 Jun; 33(6):463-74. PubMed ID: 20486729
[TBL] [Abstract][Full Text] [Related]
6. Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands.
de Vries E; Bakker E; Monster TBM; Denig P; Mol PGM
Drug Saf; 2022 Nov; 45(11):1369-1380. PubMed ID: 36107383
[TBL] [Abstract][Full Text] [Related]
7. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands.
Oosterhuis I; van Hunsel FP; van Puijenbroek EP
Drug Saf; 2012 Mar; 35(3):221-32. PubMed ID: 22201474
[TBL] [Abstract][Full Text] [Related]
8. The Awareness and Adherence of the Valproate Pregnancy Prevention Program: A Questionnaire Survey among Healthcare Professionals, Pharmacists, and Patients in Denmark.
Oliveri NMB; Hansen JM; Almarsdóttir AB; Jacobsen R
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767582
[TBL] [Abstract][Full Text] [Related]
9. Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia.
Panickar R; Aziz Z; Kamarulzaman A
BMC Public Health; 2022 Jul; 22(1):1293. PubMed ID: 35788213
[TBL] [Abstract][Full Text] [Related]
10. The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.
Piening S; de Graeff PA; Straus SM; Haaijer-Ruskamp FM; Mol PG
Drug Saf; 2013 Sep; 36(9):723-31. PubMed ID: 23797603
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
[TBL] [Abstract][Full Text] [Related]
12. Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands.
de Vries E; Denig P; de Vries ST; Monster TBM; Hugtenburg JG; Mol PGM
Drug Saf; 2020 Jul; 43(7):677-690. PubMed ID: 32212054
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
14. When direct health-care professional communications have an impact on inappropriate and unsafe use of medicines.
Reber KC; Piening S; Wieringa JE; Straus SM; Raine JM; de Graeff PA; Haaijer-Ruskamp FM; Mol PG
Clin Pharmacol Ther; 2013 Apr; 93(4):360-5. PubMed ID: 23443752
[TBL] [Abstract][Full Text] [Related]
15. Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach.
de Vries E; Bakker E; Francisca RDC; Croonen S; Denig P; Mol PGM
Drug Saf; 2022 Apr; 45(4):369-378. PubMed ID: 35349127
[TBL] [Abstract][Full Text] [Related]
16. Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018.
Højer MG; De Bruin ML; Boskovic A; Hallgreen CE
BMJ Open; 2020 May; 10(5):e036498. PubMed ID: 32398337
[TBL] [Abstract][Full Text] [Related]
17. Prescribing of rosiglitazone and pioglitazone following safety signals: analysis of trends in dispensing patterns in the Netherlands from 1998 to 2008.
Ruiter R; Visser LE; van Herk-Sukel MP; Geelhoed-Duijvestijn PH; de Bie S; Straus SM; Mol PG; Romio SA; Herings RM; Stricker BH
Drug Saf; 2012 Jun; 35(6):471-80. PubMed ID: 22540371
[TBL] [Abstract][Full Text] [Related]
18. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
19. A cross sectional survey to assess healthcare professionals' attitudes to and understanding of probiotics.
Wilson Z; Whitehead K
Clin Nutr ESPEN; 2019 Dec; 34():104-109. PubMed ID: 31677699
[TBL] [Abstract][Full Text] [Related]
20. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
